Possible association of tumor necrosis factor receptor 2 gene polymorphism with severe hypertension using the extreme discordant phenotype design

Hypertension Research

Volumn 32, Issue 9, 2009, Pages 775-779

  Eguchi, Takashi ^a   Maruyama, Tatsuya ^a   Ohno, Yoichi ^a,b   Morii, Toshiyuki ^a   Hirao, Keiichi ^a   Hirose, Hiroshi ^a   Kawabe, Hiroshi ^a   Saito, Ikuo ^a   Hayashi, Matsuhiko ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INSULIN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRON; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; ONSET AGE; PHENOTYPIC VARIATION; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

ALLELES; BLOOD PRESSURE; CASE-CONTROL STUDIES; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; JAPAN; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RESEARCH DESIGN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS;

EID: 70249148917     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.91     Document Type: Article

References (33)

1. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14 173-194.
2. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
3. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
4. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005; 46 1118-1122.
5. Pietri P, Vyssoulis G, Vlachopoulos C, Zervoudaki A, Gialernios T, Aznaouridis K, Stefanadis C. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens 2006; 24: 2231-2238.
6. Wang TJ, Gona P, Larson MG, Levy D, Benjamin EJ, Tofler GH, Jacques PF, Meigs JB, Rifai N, Selhub J, Robins SJ, Newton-Cheh C, Vasan RS. Multiple biomarkers and the risk of incident hypertension. Hypertension 2007; 49: 432-438.
7. Yu YH, Ginsberg HN. Adipocyte signaling and lipid homeostasis: Sequelae of insulin-resistant adipose tissue. Circ Res 2005; 96: 1042-1052.
8. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278-301.
9. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
10. Fernandez-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J, Richart C. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 1998; 47: 1757-1762.
11. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992; 175: 323-329.
12. Ohno Y, Suzuki H, Yamakawa H, Nakamura M, Otsuka K, Saruta T. Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: Possible role of disturbed calcium metabolism. J Hypertens 1993; 11: 421-426.
13. Morii T, Ohno Y, Hirose H, Kawabe H, Ogata T, Hirao K, Eguchi T, Maruyama T, Kanno Y, Hayashi M, Saito I, Saruta T. Cellular insulin resistance in Epstein-Barr virus-transformed lymphoblasts from young insulin-resistant Japanese men. Metabolism 2005; 54: 370-375.
14. Fernandez-Real JM, Vendrell J, Ricart W, Broch M, Gutierrez C, Casamitjana R, Oriola J, Richart C. Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care 2000; 23: 831-837.
15. Glenn CL, Wang WY, Benjafield AV, Morris BJ. Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor. Hum Mol Genet 2000; 9: 1943-1949.
16. Speirs HJL, Wang WYS, Benjafield AV, Morris BJ. No association with hypertension of CLCNKB and TNFRSF1B polymorphisms at a hypertension locus on chromosome 1p36. J Hypertens 2005; 23: 1491-1496.
17. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J Natl Cancer Inst 2004; 96 434-442.
18. Ohno Y, Tanase H, Nabika T, Otsuka K, Sasaki T, Suzawa T, Morii T, Yamori Y, Saruta T. Selective genotyping with epistasis can be utilized for a major quantitative trait locus mapping in hypertension in rats. Genetics 2000; 155: 785-792.
19. Van Gestel S, Houwing-Duistermaat JJ, Adolfsson R, van Duijn CM, Van Broeckhoven C. Power of selective genotyping in genetic association analyses of quantitative traits. Behav Genet 2000; 30: 141-146.
20. Zhang G, Nebert DW, Chakraborty R, Jin L. Statistical power of association using the extreme discordant phenotype design. Pharmacogenet Genomics 2006; 16: 401-413.
21. Lida M, Ueda K, Okayama A, Kodama K, Sawai K, Shibata S, Tanaka S, Keijnkai T, Horibe H, Minowa M, Yanagawa H, Hashimoto T. Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese - Nippon data 80. J Hum Hypertens 2003; 17: 851-857.
22. Tozawa M, Oshiro S, Iseki C, Sesoko S, Higashiuesato Y, Tana T, Ikemiya Y, Iseki K, Fukiyama K. Family history of hypertension and blood pressure in a screened cohort. Hypertens Res 2001; 24: 93-98.
23. Weidmann P, Bohlen L, de Courten M. Insulin resistance and hyperinsulinemia in hypertension. J Hypertens Suppl 1995; 13 S65-S72.
24. Ikegami H, Yamato E, Fujisawa T, Hamada Y, Fujioka Y, Rakugi H, Higaki J, Murakami H, Shimamoto K, Ogihara T. Analysis of candidate genes for insulin resistance in essential hypertension. Hypertens Res 1996; 19 (Suppl 1): S31-S34.
25. Poch E, Giner V, Gonzalez-Nunez D, Coll E, Oriola J, de la Sierra A. Association of the G protein beta3 subunit T allele with insulin resistance in essential hypertension. Clin Exp Hypertens 2002; 24: 345-353.
26. Yamamoto J, Kageyama S, Nemoto M, Sasaki T, Sakurai T, Ishibashi K, Mimura A, Yokota K, Tajima N. PPARgamma2 pro12Ala polymorphism and insulin resistance in Japanese hypertensive patients. Hypertens Res 2002; 25: 25-29.
27. Olivier M, Hsiung CA, Chuang LM, Ho LT, Ting CT, Bustos VI, Lee TM, De Witte A, Chen YD, Olshen R, Rodriguez B, Wen CC, Cox DR. Single nucleotide polymorphisms in protein tyrosine phosphatase 1beta (PTPN1) are associated with essential hypertension and obesity. Hum Mol Genet 2004; 13: 1885-1892.
28. Nophar Y, Kemper O, Brakebusch C, Englemann H, Zwang R, Aderka D, Holtmann H, Wallach D. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J 1990; 9: 3269-3278.
29. McCarron RM, Wang L, Siren AL, Spatz M, Hallenbeck JM. Monocyte adhesion to cerebromicrovascular endothelial cells derived from hypertensive and normotensive rats. Am J Physiol 1994; 267: H2491-H2497.
30. Aggarwal BB. Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 2003; 3: 745-756.
31. Fernandez-Real JM, Lainez B, Vendrell J, Rigla M, Castro A, Penarroja G, Broch M, Perez A, Richart C, Engel P, Ricart W. Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2002; 282: E952-E959.
32. Agarwal AK, Giacchetti G, Lavery G, Nikkila H, Palermo M, Ricketts M, McTernan C, Bianchi G, Manunta P, Strazzullo P, Mantero F, White PC, Stewart PM. CA-Repeat polymorphism in intron 1 of HSD11B2: Effects on gene expression and salt sensitivity. Hypertension 2000; 36: 187-194.
33. Brandt B, Meyer-Staeckling S, Schmidt H, Agelopoulos K, Buerger H. Mechanisms of egfr gene transcription modulation: Relationship to cancer risk and therapy response. Clin Cancer Res 2006; 12: 7252-7260.